255 results on '"Lanteri, Marion C."'
Search Results
2. Associations of Temporal Cardiometabolic Patterns and Incident SARS-CoV-2 Infection Among U.S. Blood Donors With Serologic Evidence of Vaccination
3. Zika virus RNA and IgM persistence in blood compartments and body fluids: a prospective observational study
4. Detection of anti-nucleocapsid antibodies associated with primary SARS-CoV-2 infection in unvaccinated and vaccinated blood donors
5. Frequent blood donations alter susceptibility of red blood cells to storage‐ and stress‐induced hemolysis
6. Blood Gene Signatures of Chagas Cardiomyopathy With or Without Ventricular Dysfunction
7. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome
8. Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status--United States, April 2021-September 2022
9. Soluble T Cell Immunoglobulin Mucin Domain 3 Is Shed from CD8+ T Cells by the Sheddase ADAM10, Is Increased in Plasma during Untreated HIV Infection, and Correlates with HIV Disease Progression
10. Galectin-9 Is Rapidly Released During Acute HIV-1 Infection and Remains Sustained at High Levels Despite Viral Suppression Even in Elite Controllers
11. End of selection criteria based on sexual orientation: An international symposium on alternatives to donation deferral.
12. Syphilis seroprevalence and incidence in US blood donors from 2020 to 2022.
13. Zika virus in French Polynesia 2013–14: anatomy of a completed outbreak
14. An update on Zika virus infection
15. Multiple-ancestry genome-wide association study identifies 27 loci associated with measures of hemolysis following blood storage
16. Plasma transfusion–transmission of Zika virus in mice and macaques
17. Downregulation of Cytokines and Chemokines by GB Virus C After Transmission Via Blood Transfusion in HIV-Positive Blood Recipients
18. Inactivation of chikungunya virus in blood components treated with amotosalen/ultraviolet A light or amustaline/glutathione
19. Pathogen inactivation of Dengue virus in red blood cells using amustaline and glutathione
20. Human memory T cells with a naive phenotype accumulate with aging and respond to persistent viruses
21. Thoughts Around the Zika Virus Crisis
22. Mitigating the risk of transfusion‐transmitted infections with vector‐borne agents solely by means of pathogen reduction
23. Molecular detection of Zika virus in blood and RNA load determination during the French Polynesian outbreak
24. Amustaline (S‐303) treatment inactivates high levels of Zika virus in red blood cell components
25. Relative analytical sensitivity of donor nucleic acid amplification technology screening and diagnostic real‐time polymerase chain reaction assays for detection of Zika virus RNA
26. Robust inactivation of Plasmodium falciparum in red blood cell concentrates using amustaline and glutathione pathogen reduction
27. Quantitative restoration of immune defense in old animals determined by naive antigen‐specific CD8 T‐cell numbers
28. Interferon and Interferon-Induced Chemokine Expression Is Associated with Control of Acute Viremia in West Nile Virus–Infected Blood Donors
29. Comprehensive Analysis of West Nile Virus-Specific T Cell Responses in Humans
30. Quantitative Restoration of Immune Defense in Old Animals Determined by Naïve Antigen-Specific CD8 T cell Numbers
31. West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety
32. Tregs control the development of symptomatic West Nile virus infection in humans and mice
33. Dengue in the context of “safe blood” and global epidemiology: to screen or not to screen?
34. Sepsis from an apheresis platelet contaminated withAcinetobacter calcoaceticus/baumanniicomplex bacteria andStaphylococcus saprophyticusafter pathogen reduction
35. Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light
36. Inactivation ofPlasmodium falciparumin whole blood using the amustaline and glutathione pathogen reduction technology
37. Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen‐reduction technology
38. Corrigendum to: Blood Gene Signatures of Chagas Cardiomyopathy With or Without Ventricular Dysfunction
39. Differential Pattern of Soluble Immune Markers in Asymptomatic Dengue, West Nile and Zika Virus Infections
40. Progress towards an appropriate pathogen reduction technology for whole blood in Africa
41. HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses
42. In vitro evaluation of pathogen inactivated platelet quality: An 8 year experience of routine use in Galicia, Spain
43. Sepsis from an apheresis platelet contaminated with Acinetobacter calcoaceticus/baumannii complex bacteria and Staphylococcus saprophyticus after pathogen reduction.
44. Inactivation of Plasmodium falciparum in whole blood using the amustaline and glutathione pathogen reduction technology.
45. Progress towards an appropriate pathogen reduction technology for whole blood in Africa.
46. Documentation of transfusion-transmitted arbovirus infections in endemic areas
47. Inactivation des arbovirus dans les produits sanguins labiles
48. Zika virus in Singapore: unanswered questions
49. Inactivation of Zika virus in platelet components using amotosalen and ultraviolet A illumination
50. Ethnicity, sex, and age are determinants of red blood cell storage and stress hemolysis: results of the REDS-III RBC-Omics study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.